Red cell substitutes from hemoglobin-Do we start all over again?

Current Opinion in Chemical Biology

Volumn 14, Issue 4, 2010, Pages 538-543

  Kluger, Ronald ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; DEOXYHEMOGLOBIN; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; MACROGOL; NITRIC OXIDE; NITRITE; NITRITE REDUCTASE; OXYHEMOGLOBIN;

BLOOD FLOW; BLOOD PRESSURE; CAPILLARY; CARDIOVASCULAR RISK; CIRCULATION; CLINICAL TRIAL; CONJUGATE; ENZYME ACTIVITY; ERYTHROCYTE; HEART INFARCTION; HUMAN; INTRAVASCULAR SPACE; OXIDATION; OXYGEN AFFINITY; REVIEW; SIGNAL TRANSDUCTION; TISSUE OXYGENATION; VASODILATATION;

BLOOD SUBSTITUTES; DRUG DISCOVERY; HEMOGLOBINS; HUMANS; MOLECULAR STRUCTURE;

EID: 77955321374     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2010.03.021     Document Type: Review

References (73)

1. Keipert P., Minkowitz J., Chang T.M.S. Crosslinked stroma-free polyhemoglobin as a potential blood substitute. Int J Artif Organs 1982, 5:383-385.
2. Sehgal L.R., Gould S.A., Rosen A.L., Sehgal H.L., Moss G.S. Appraisal of red cell substitutes: hemoglobin solution and perfluorochemical emulsions. Lab Med 1983, 14:545-548.
3. Pschenyczny V., Nho K., Gilbert C.W., Shorr R. Is hemoglobinuria an indication of HBOC toxicity. FASEB J 1992, 6:A2014.
4. Vandegriff K.D. Haemoglobin-based oxygen carriers. Exp Opin Investig Drugs 2000, 9:1967-1984.
5. Hughes G.S., Yancey E.P., Albrecht R., Locker P.K., Francom S.F., Orringer E.P., Antal E.J., Jacobs E.E. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans. Clin Pharm Ther 1995, 58:434-443.
6. Winslow R.M. Blood substitutes-current status. Transfusion 1989, 29:753-754.
7. Winslow R.M. Blood substitutes. Adv Drug Del Rev 2000, 40:131-142.
8. Sanders K.E., Ackers G., Sligar S. Engineering and design of blood substitutes. Curr Opin Struct Biol 1996, 6:534-540.
9. Stowell C.P. What happened to blood substitutes?. Transfus Clin Biol 2005, 12:374-379.
10. Bian K., Murad F. Nitric oxide (NO)-biogeneration, regulation, and relevence to human diseases. Front Biosci 2003, 8:D264-D278.
11. Marsh N., Marsh A. A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol 2000, 27:313-319.
12. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996, 380:221-226.
13. Drobin D., Kjellstrom B.T., Malm E., Malavalli A., Lohman J., Vandegriff K.D., Young M.A., Winslow R.M. Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4). J Appl Physiol 2004, 96:1843-1853.
14. Thompson A. Etobickoke firm in hot race to produce artificial blood. Toronto Star 1992, c1-c2. September 29.
15. US Food and Drug Administration: Guidance for Industry: Criteria for Safety and Efficacy Evaluation of Oxygen Therapeutics as Red Blood Cell Substitutes. Washington, D.C.; 2004:1-19.
16. Jaspen B. FDA shoots down Northfield Labs blood substitute. Chicago Tribune 2009, April 30.
17. Estep T., Bucci E., Farmer M., Greenburg G., Harrington J., Kim H.W., Klein H., Mitchell P., Nemo G., Olsen K., et al. Basic science focus on blood substitutes: a summary of the NHLBI division of blood diseases and resources working group workshop, March 1, 2006. Transfusion 2008, 48:776-782.
18. Harris D.R., Palmer A.F. Modern cross-linking strategies for synthesizing acellular hemoglobin-based oxygen carriers. Biotechnol Prog 2008, 24:1215-1225.
19. Tsai A.G., Cabrales P., Intaglietta M. Oxygen-carrying blood substitutes: a microvascular perspective. Exp Opin Biol Ther 2004, 4:1147-1157.
20. Benesch R.E., Kwong S. Hemoglobin tetramers stabilized by a single intramolecular cross-link. J Protein Chem 1991, 10:503-510.
21. Caccia D., Ronda L., Frassi R., Perrella M., Del Favero E., Bruno S., Pioselli B., Abbruzzetti S., Viappiani C., Mozzarelli A. PEGylation promotes hemoglobin tetramer dissociation. Bioconjug Chem 2009, 20:1356-1366.
22. Kroeger K.S., Kundrot C.E. Structures of a hemoglobin-based blood substitute: insights into the function of allosteric proteins. Structure 1997, 5:227-237.
23. Looker D., Abbottbrown D., Cozart P., Durfee S., Hoffman S., Mathews A.J., Millerroehrich J., Shoemaker S., Trimble S., Fermi G., et al. A human recombinant hemoglobin designed for use as a blood substitute. Nature 1992, 356:258-260.
24. Satoh T., Kobayashi K., Sekiguchi S., Tsuchida E. Characteristics of artificial red cells. Hemoglobin encapsulated in poly-lipid vesicles. ASAIO J 1992, 38:M580-584.
25. Tsuchida E., Komatsu T., Kawai N., Nishide H., Kakizaki T., Kobayashi K. Preparation and oxygen transport of artificial red cells (lipidheme microspheres). Artif Org Today 1993, 3:137-143.
26. Keipert P.E., Gomez C.L., Gonzales A., MacDonald V.W., Hess J.R., Winslow R.M. Diaspirin cross-linked hemoglobin: tissue distribution and long-term excretion after exchange transfusion. J Lab Clin Med 1994, 123:701-711.
27. Simoni J., Simoni G., Hartsell A., Feola M. An improved blood substitute-in vivo evaluation of its renal effects. ASAIO J 1997, 43:M714-M725.
28. Wrighton S., Chow E.C.Y., Liu L., Ship N., Kluger, Pang K.S. Role of haptoglobin on the uptake of native and β-chain [trimesyl-(lys82)β(ys82)β] cross-linked human hemoglobins in isolated perfused rat livers. Drug Metab Disp 2008, 36:937-945.
29. Ship N.J., Toprak A., Lai R.P., Tseng E., Kluger R., Pang K.S. Binding of acellular, native and cross-linked human hemoglobins to haptoglobin: enhanced distribution and clearance in the rat. Am J Physiol Gastrointest Liv Physiol 2005, 288:G1301-G1309.
30. Habeeb A.F.S.A., Hiramoto R. Reaction of proteins with glutaraldehyde. Arch Biochem Biophys 1968, 126:16-26.
31. Benesch R., Benesch R.E., Yung P.S., Edalji R. Hemoglobin covalently bridged across the polyphosphate binding site. Biochem Biophys Res Commun 1975, 63:1123-1129.
32. Snyder S.R., Welty E.V., Walder R.Y., Williams L.A., Walder J.A. HbXL99a: a hemoglobin derivaitve that is cross-linked between the a subunits is useful as a blood substitute. Proc Natl Acad Sci U S A 1987, 84:7280-7284.
33. Kluger R., Grant A.S., Bearne S.L., Trachsel M.R. Dicarboxylic acid bis(methyl phosphates): anionic biomimetic cross-linking reagents. J Org Chem 1990, 55:2864-2868.
34. Vandegriff K.D., Winslow R.M. Hemoglobin-based blood substitutes. Chem Ind 1991, 497.
35. Rausch CW, Gawryl MS, Houtchens RA, Laccetti AJ, Light WR: Method for producing a stable polymerized hemoglobin blood-substitute. US Patent 1999, 5955581.
36. Eike J.H., Palmer A.F. Effect of glutaraldehyde concentration on the physical properties of polymerized hemoglobin-based oxygen carriers. Biotechnol Prog 2004, 20:1225-1232.
37. Natanson C., Kern S.J., Lurie P., Banks S.M., Wolfe S.M. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. J Am Med Assoc 2008, 299:2304-2312.
38. Massil S.E., Shi G.Y., Klotz I.M. Acylation of hemoglobin by aspirin-like diacyl esters. J Pharm Sci 1984, 73:1013-1014.
39. Walder J.A., Zaugg R.H., Walder R.Y., Steele J.M., Klotz I.M. Diaspirins that cross-link beta-chains of hemoglobin-bis-(3,5-dibromosalicyl) succinate and bis-(3,5-dibromosalicyl) fumarate. Biochemistry 1979, 18:4265-4270.
40. Klotz I.M., Haney D.N., King L.C. Rational approaches to chemotherapy. Antisickling agents. Science (Washington D.C.) 1981, 213:724-731.
41. Manning J.M. Covalent inhibitors of the gelation of sickle cell hemoglobin and their effects on function. Adv Enzymol 1991, 64:55-91.
42. Kluger R., De Stefano V. Mechanism of site-directed protein cross-linking. Protein-directed selectivity in reactions of hemoglobin with aryl trimesates. J Org Chem 2000, 65:214-219.
43. Kluger R. Acyl phosphate esters: charge-directed acylation and aritficial blood. Synlett 2000, 12:1708-1720.
44. Grant A., Bearne S., Kluger R. Site-directed modifiers of proteins-acyl phosphate monoesters and their bifunctional analogs. Biochemistry 1988, 27:3098.
45. Kluger R., Shen L., Xiao H., Jones R.T. Systematically cross-linked human hemoglobin: functional effects of 10Å spans between beta subunits at lysine-82. J Am Chem Soc 1996, 118:8782-8786.
46. Schumacher M.A., Dixon M.M., Kluger R., Jones R.T., Brennan R.G. Allosteric transition intermediates modeled by cross-linked hemoglobins. Nature 1995, 375:84-87.
47. Erhart S.M., Cole D.J., Patel P.M., Drummond J.C., Burhop K.E. Effect of alpha-alpha diaspirin crosslinked hemoglobin (DCLHb (TM)) on the potency of sodium nitroprusside and nitroglycerine to decrease blood pressure in rats: a dose-response study. Artif Cells Blood Subs Immob Biotechnol 2000, 28:385-396.
48. Schultz S.C., Grady B., Cole F., Hamilton I., Burhop K., Malcolm D.S. A role for endothelin and nitric-oxide in the pressor-response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993, 122:301-308.
49. Vandegriff K.D., Malavalli A., Wooldridge J., Lohman J., Winslow R.M. MP4: a new nonvasoactive PEG-Hb conjugate. Transfusion 2003, 43:509-516.
50. Winslow R.M., Keipert P., Winslow N., Olofsson N., Fagrell B., Ahl T., Johansson T., Larsson S., Nellgard P., Ponzer S., et al. A multi-center study of the safety and efficacy of MP4 (Hemospan (R)) in orthopedic surgery patients. Crit Care Med 2005, 33:A6.
51. Vandegriff K., Bellelli A., Samaja M., Malavalli A., Brunori M., Winslow R.M. Rates of NO binding to MP4, a non-hypertensive polyethylene glycol-conjugated hemoglobin. FASEB J 2003, 17:A183.
52. Vandegriff K.D., Malavalli A., Minn C., Jiang E., Lohman J., Young M.A., Samaja M., Winslow R.M. Oxidation and haem loss kinetics of poly(ethylene glycol)-conjugated haemoglobin (MP4): dissociation between in vitro and in vivo oxidation rates. Biochem J 2006, 399:463-471.
53. Vazquez B.Y.S., Wettstein R., Cabrales P., Tsai A.G., Intaglietta M. Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation. Biochim Biophys Acta Proteins Proteom 2008, 1784:1421-1427.
54. Sangart, Inc., San Diego, CA; 2009. Available online at: http://www.sangart.com/products/mp4ox.htm.
55. Villela N.R., Cabrales P., Tsai A.G., Intaglietta M. Microcirculatory effects of changing blood hemoglobin oxygen affinity during hemorrhagic shock resuscitation in an experimental model. Shock 2009, 31:645-652.
56. Vandegriff K.D., McCarthy M., Rohlfs R.J., Winslow R.M. Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated. Biophys Chem 1997, 69:23-30.
57. Olson J.S., Foley E.W., Rogge C., Tsai A.L., Doyle M.P., Lemon D.D. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004, 36:685-697.
58. Brooks J. The action of nitrite on haemoglobin in the absence of oxygen. Proc Royal Soc Lond Ser B Biol Sci 1937, 123:368-382.
59. Cannon R.O., Schechter A.N., Panza J.A., Ognibene F.P., Pease-Fye M.E., Waclawiw M.A., Shelhamer J.H., Gladwin M.T. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001, 108:279-287.
60. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X., et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003, 9:1498-1505.
61. Dejam A., Hunter C.J., Schechter A.N., Gladwin M.T. Emerging role of nitrite in human biology. Blood Cells Mol Dis 2004, 32:423-429.
62. Huang Z., Shiva S., Kim-Shapiro D.B., Patel R.P., Ringwood L.A., Irby C.E., Huang K.T., Ho C., Hogg N., Schechter A.N., et al. Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest 2005, 115:2099-2107.
63. Kim-Shapiro D.B., Gladwin M.T., Patel R.P., Hogg N. The reaction between nitrite and hemoglobin: the role of nitrite in hemoglobin-mediated hypoxic vasodilation. J Inorg Biochem 2005, 99:237-246.
64. Gladwin M.T., Grubina R., Doyle M.P. The new chemical biology of nitrite reactions with hemoglobin: R-state catalysis, oxidative denitrosylation, and nitrite reductase/anhydrase. Acc Chem Res 2009, 42:157-167.
65. Lui F.E., Dong P., Kluger R. Polyethylene glycol conjugation enhances the nitrite reductase activity of native and cross-linked hemoglobin. Biochemistry 2008, 47:10773-10780.
66. Lui F.E., Kluger R. Enhancing nitrite reductase activity of modified hemoglobin: bis-tetramers and their PEGylated derivatives. Biochemistry 2009, 48:11912-11919.
67. Gourianov N., Kluger R. Crosslinked bis-hemoglobins: connections and oxygen binding. J Am Chem Soc 2003, 125:10885-10892.
68. Gourianov N., Kluger R. Conjoined hemoglobins. Loss of cooperativity and protein-protein interactions. Biochemistry 2005, 44:14989-14999.
69. Hu D.X., Kluger R. Functional cross-linked hemoglobin bis-tetramers: geometry and cooperativity. Biochemistry 2008, 47:12551-12561.
70. Hu T., Li D., Manjula B.N., Brenowitz M., Prabhakaran M., Acharya S.A. PEGylation of Val-1(α) destabilizes the tetrameric structure of hemoglobin. Biochemistry 2009, 48:608-616.
71. Bucci E., Kwansa H., Koehler R.C., Matheson B. Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion. Artif Cells Blood Subs Biotechnol 2007, 35:11-18.
72. Harnois T., Rousselot M., Rogniaux H., Zal F. High-level production of recombinant arenicola marina globin chains in Escherichia coli: a new generation of blood substitute. Artif Cells Blood Subs Biotechnol 2009, 37:106-116.
73. Baudin-Creuza V., Chauvierre C., Domingues E., Kiger L., Leclerc L., Vasseur C., Celier C., Marden M.C. Octamers and nanoparticles as hemoglobin based blood substitutes. Biochim Biophys Acta Prot Proteom 2008, 1784:1448-1453.